Best peptides for wrinkles
Science-backed peptides that target fine lines, expression wrinkles, and skin aging.
Anti-aging peptides are one of the few cosmetic active categories with real clinical data behind them. They work through several mechanisms — stimulating collagen production, modestly relaxing facial muscles, or reducing inflammation that accelerates aging. Here are the peptides with the strongest evidence for wrinkle reduction.
Anti-aging collagen stimulator widely used in anti-aging serums. One of the most well-studied cosmetic peptides with a strong track record for reducing fine lines.
What evidence supports
- ✓stimulates collagen I and fibronectin production in fibroblasts
- ✓may reduce wrinkle depth with consistent use over 8–12 weeks
- ✓well-tolerated in clinical studies
Key concern: rarely irritating but possible with very sensitive skin
Available in
One of the most researched peptides in cosmetic science. Naturally occurring in human plasma, GHK-Cu declines with age and is involved in wound healing, collagen synthesis, and potentially hair growth.
What evidence supports
- ✓promotes wound healing and tissue repair in multiple studies
- ✓stimulates collagen and glycosaminoglycan synthesis
- ✓may support hair follicle health and growth in some studies
Key concern: can cause a purging-like skin response initially
"Botox in a bottle" claims surround this muscle-relaxing peptide. Marketed for expression lines, though its real-world effect is significantly more modest than injectable neurotoxins.
What evidence supports
- ✓may modestly reduce wrinkle depth at 10% concentration in controlled studies
- ✓topical penetration limits how much reaches the muscle
- ✓effect is reversible and requires ongoing use
Key concern: effect is much weaker than injectable Botox
Available in
A collagen-boosting signal peptide most often paired with Palmitoyl Tetrapeptide-7 to form the Matrixyl 3000 complex. Popular in anti-aging formulations aimed at mature or sensitive skin.
What evidence supports
- ✓in vitro studies show stimulation of collagen I and III production in fibroblasts
- ✓modest wrinkle reduction observed in in vivo studies over several weeks
- ✓generally well-tolerated including in sensitive skin
Key concern: typically well-tolerated with minimal irritation risk
Available in
An antioxidant dipeptide found naturally in muscle and brain tissue. Studied for its anti-glycation properties that protect proteins from sugar-related damage linked to aging.
What evidence supports
- ✓demonstrated antioxidant and anti-glycation properties in cell studies
- ✓may protect against protein cross-linking associated with aging
- ✓found naturally in high concentrations in muscle and nervous tissue
Key concern: oral bioavailability is limited — the enzyme carnosinase breaks it down in the bloodstream
Available in
An extended version of Argireline (from 6 to 8 amino acids) marketed as a more potent "Botox alternative" for expression lines. Targets the same SNARE complex mechanism but claims improved efficacy through the additional amino acids.
What evidence supports
- ✓in vitro studies show SNARE complex inhibition similar to Argireline
- ✓manufacturer studies claim up to 63% wrinkle reduction at 10% concentration in 28 days
- ✓mechanism of action is scientifically plausible and well-characterized
Key concern: most efficacy data comes from the manufacturer (Lipotec/Lubrizol), not independent studies
An anti-inflammatory signal peptide most commonly found paired with Palmitoyl Tripeptide-1 in the Matrixyl 3000 complex. While Palmitoyl Tripeptide-1 stimulates collagen production, Tetrapeptide-7 works to reduce inflammation and skin damage from UV exposure.
What evidence supports
- ✓demonstrated IL-6 suppression in in vitro studies
- ✓shown to reduce inflammation-related skin damage in combination studies
- ✓synergistic anti-aging effects when combined with Palmitoyl Tripeptide-1 (Matrixyl 3000)
Key concern: almost always studied in combination with Palmitoyl Tripeptide-1, making standalone efficacy hard to assess
Available in
A naturally occurring tripeptide found in human plasma, saliva, and urine. Concentrations decline significantly with age. GHK is the foundation peptide that, when bound to copper, forms the more well-known GHK-Cu. On its own, GHK has wound healing and gene expression modulation properties.
What evidence supports
- ✓gene expression studies show GHK can upregulate genes associated with tissue repair and downregulate inflammatory genes
- ✓stimulates collagen I and III synthesis in fibroblast cultures
- ✓promotes wound healing in animal models
Key concern: most research is on GHK-Cu (copper-bound form) rather than free GHK alone
A synthetic enkephalin-analog pentapeptide that targets the opioid signaling pathway at the neuromuscular junction to modestly relax facial muscles. Designed to work synergistically with Argireline (Acetyl Hexapeptide-8), which targets a different step in the same muscle contraction pathway. Often combined with Argireline in professional anti-aging formulations.
What evidence supports
- ✓in vitro: Pentapeptide-18 reduces acetylcholine vesicle release from nerve terminals
- ✓small company-sponsored study: wrinkle depth reduction comparable to Argireline at 4% concentration
- ✓Lipotec combination study: Leuphasyl + Argireline showed ~24% wrinkle depth reduction vs ~11.5% for either alone (28 days)
Key concern: independent clinical trials extremely limited — most data from originating manufacturer (Lipotec)
Available in
A palmitoylated tripeptide developed by DSM (now dsm-firmenich) under the trademark Syn-Coll. Designed to stimulate collagen synthesis via the TGF-β signaling pathway, offering a mechanistic complement to Matrixyl-type peptides that work through extracellular matrix fragment mimicry.
What evidence supports
- ✓in vitro: Pal-Lys-Val-Lys significantly increases Type I collagen expression in human fibroblast cultures
- ✓manufacturer-sponsored in vivo study: improved skin firmness and wrinkle depth reduction after 84 days at 3% concentration
- ✓mechanism via TGF-β1 pathway is pharmacologically plausible and supported by cell culture data
Key concern: clinical evidence primarily manufacturer-sponsored (DSM) with limited independent trials
A synthetic tetrapeptide developed specifically for the periorbital area, targeting under-eye puffiness and dark circles through reduction of capillary permeability and improvement of lymphatic drainage. Marketed under the trademark Eyeseryl by Lipotec (Lubrizol Advanced Materials).
What evidence supports
- ✓manufacturer study (Lipotec): 20% reduction in under-eye edema measured by 3D imaging after 28 days at 4% concentration
- ✓in vitro data shows reduction in capillary permeability markers in endothelial cell cultures
- ✓anti-glycation activity documented in cell culture studies
Key concern: evidence limited to manufacturer-sponsored studies — no independent clinical trials
Not sure which is right for you?
Take our quiz for a personalized recommendation based on your goals and preferences.
Take the Peptide QuizMedical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.